CorMedix (CRMD) Interest Expenses (2012 - 2025)

CorMedix has disclosed Interest Expenses across 13 years of filings, most recently posting $1.8 million for Q4 2025.

• Interest Expenses for Q4 2025 came in at $1.8 million, up 18823.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (up 7627.78% YoY), and the FY2025 annual result was $2.8 million, up 7627.78% from the prior year.
• Interest Expenses came in at $1.8 million for Q4 2025 at CorMedix, up from $948242.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.8 million in Q4 2025 to a low of $3585.0 in Q2 2022.
• The 5-year median for Interest Expenses is $8775.0 (2022), against an average of $152355.4.
• Across the five-year window, Interest Expenses tumbled 31.01% in 2021 and soared 18823.96% in 2025, its largest moves.
• CorMedix's Interest Expenses stood at $5378.0 in 2021, then soared by 63.16% to $8775.0 in 2022, then decreased by 25.29% to $6556.0 in 2023, then jumped by 46.46% to $9602.0 in 2024, then jumped by 18823.96% to $1.8 million in 2025.
• The last three Interest Expenses figures came in at $1.8 million (Q4 2025), $948242.0 (Q3 2025), and $6671.0 (Q2 2025), per Business Quant data.